Integrative Approach to Predict Severity in Nonketotic Hyperglycinemia

Area of Science:

• Neurometabolic disorders
• Neurogenetics
• Clinical biochemistry

Background:

• Glycine encephalopathy (nonketotic hyperglycinemia, NKH) is a rare inherited neurometabolic disorder with a wide range of clinical presentations.
• Accurate characterization of NKH phenotypes and reliable prediction of disease severity are crucial for effective clinical management.

Purpose of the Study:

• To precisely characterize the phenotype of Glycine encephalopathy (NKH).
• To evaluate predictive approaches for disease severity in NKH.
• To identify new pathogenic variants in GLDC and AMT genes.

Main Methods:

• Analysis of longitudinal clinical and biochemical data from 25 NKH patients.
• In silico analyses, pathogenicity scoring, and molecular modeling of GLDC and AMT variants.
• Statistical evaluation of clinical and biochemical markers for predicting disease severity.

Main Results:

• Symptom onset and diagnosis occur earlier in severe NKH.
• Specific thresholds for age at onset, cerebrospinal fluid (CSF)/plasma glycine ratio, and CSF glycine concentration effectively differentiate between attenuated and severe NKH.
• Ten novel GLDC variants were identified, with genotype-phenotype correlations observed.

Conclusions:

• This study expands the known phenotypic spectrum of attenuated NKH and identifies new pathogenic variants.
• A multiparametric approach combining clinical, biochemical, and genetic data offers a promising tool for predicting NKH severity.
• Improved prediction of disease severity can enhance clinical management strategies for patients with Glycine encephalopathy.